경영·경제 질문은 AI 비서에게,
무엇이든 물어보세요.
로그인 후 질문을 입력해주세요
소개영상보기
Public Health
Hair Loss Recognized as Disease from Follicle Damage
In recent academic discourse, there is growing recognition of hair loss as a disease of modern people. Getty Images Bank After President Lee Jae-myung stated during the Ministry of Health and Welfare’s year-end 2025 policy briefing that “hair loss is a matter of survival,” controversy has reignited in political circles over whether hair loss treatment should be covered by the National Health Insur
2026.02.02
MedTech
Celltrion Internalizes Hyaluronidase SC Formulation Technology
2026.02.02
MedTech
OLED “Hair-Loss Cap” Claims 92% Cell Aging Cut
2026.02.01
MedTech
Korean Team Develops Light-Based Cancer Cell Therapy
2026.02.06
Global Business
Korea United Pharm speeds Vietnam push, targets double cancer drug sales
2026.02.05
Recent Articles
-
Medical / ResearchScientists Find Fat Cell ‘Switch,’ Paving Way for Precise Obesity, Fatty Liver TreatmentsGetty Images Bank With the emergence of obesity treatments that can be taken as pills instead of injections, interest in obesity treatment is growing even hotter in Korea. The obesity treatments known as “Wegovy” and “Mounjaro” belong to the glucagon-like peptide-1 (GLP-1) class. GLP-1-based obesity2026.01.26 -
Pharmaceutical R&DUniversal Blood Type Developed, Surpassing Donation LimitsOn January 13, Artblood CEO Baek Eun-jung (Professor of Laboratory Medicine at Hanyang University Hospital) points to a container filled with rapidly proliferating red blood cells at the company’s research institute in Seocho-gu, Seoul, explaining the technology for cell line-based artificial red bl2026.01.24 -
Pharmaceutical R&DSK Bioscience Completes Global R&PD Center in SongdoPanoramic view of SK bioscience’s Global R&PD Center. Courtesy of SK bioscience SK bioscience announced on the 23rd that it has completed its “Global R&PD Center” in Songdo International City, Yeonsu-gu, Incheon.The center was established to develop the Songdo bio cluster into an advanced research-b2026.01.23 -
MedTechUltra V Plant 2 Gains KGMP Nod, Boosts UltaCol OutputPhoto provided by UltraV Global bio-medical beauty group UltraV (UltraV, CEO Kwon Han-jin) has obtained certification for the Good Manufacturing Practice for Medical Devices and Quality Management (KGMP) for its Hyangdong plant and has commenced operation of a second manufacturing site to expand pro2026.01.23 -
Medical / Clinical CaseSarangi Women’s Clinic Reports Implantation After BSC ProcedureDirector Park Joo-hee of Sarang-i Women’s Clinic. Provided by Sarang-i Women’s Clinic Director Park Joo-hee of Sarang-i Women’s Clinic, a medical institution specializing in infertility clinics, stated on the 23rd that she had observed cases in which embryo implantation was confirmed during in vitro2026.01.23 -
BiotechK-Run, Osong Foundation, Young Science Sign Nucleic Acid Therapy GMP Infrastructure Deal(From left) Young Science CEO Jung Tae-hoon, Osong Foundation Biopharmaceutical Production Center Director Kim Hyun-il, and K-Run CEO Han Cheong-su signed a three-party agreement. Photo provided by Osong Medical Innovation Foundation K-Run Co., Ltd. (CEO Han Cheong-su) announced that on the 20th it2026.01.23 -
MedTechInha University Hospital Boosts Education, Research, Care with ‘Future Human Project’On the 21st, Lee Taek, Director of Inha University Medical Center, stressed on the occasion of the 30th anniversary of the hospital’s opening that “through the ‘Future-IN Project,’ which will redesign the hospital’s space, functions, and systems to further advance the medical system, the hospital wi2026.01.23 -
Global Trend / HealthcareBig Tech Ramps Up AI Healthcare BattleAmazon is launching a healthcare management tool that uses artificial intelligence (AI). With OpenAI and Anthropic each rolling out AI tools this month to help users manage their health and handle medical administration, competition in “AI healthcare” involving major AI companies is entering a full-2026.01.23 -
Clinical TrialHK inno.N Completes Phase 3 Enrollment for GLP-1 Obesity DrugHK inno.N announced on the 22nd that it has completed enrollment of subjects for the domestic Phase 3 clinical trial of its new GLP-1 receptor agonist obesity treatment “IN-B00009 (generic name: ecnoglutide).”HK inno.N received approval for the Phase 3 clinical trial plan (IND) for IN-B00009 from th2026.01.22 -
Medical / ResearchDaewoong Foundation Backs 20 Young Medical Scientists, Expands Aging and Drug R&DDaewoong Pharmaceutical headquarters Daewoong Foundation announced on the 22nd that it has finally selected a total of 20 research projects through the “New Medical Scientist Academic Research Support Program,” which supports young medical scientists. Each selected researcher will receive up to KRW2026.01.22
